HAL9000, & ALL: Fonar Corp. Nasdaq Small-Cap (FONR) Current price $2.06 Bid, $2.09 Ask.
52 week range $2.25 to $4.06
Fonar's web site__________________________ fonar.com
Be sure to research past announcements to get the BIG PICTURE....
FONR has won against General Electric ALL the way through the Supreme Court.
GE has already paid FONR $128.7 Million for MRI patent infringement. The Court
signed an injunction against General Electric. GE still does NOT have LICENSING &
ROYALTY Agreements with FONR, which is believed to be going to bring Fonar
Corp. many more Millions.
FONR has also been successful in defending their patent rights against Hitachi, Philips,
& Siemens.
FONR is receiving an infusion of cash and should begin
receiving royalties from its competition who wish to continue to use its Multi-Angle
Oblique Technology which is highly regarded as the industry standard.
Fonar maintains a healthy balance sheet which will become stronger quarter by quarter
due to royalties and one-time cash infusions.
Long-term solid support in the $2.00 to $2.50 area, the stock is a recommendation by
The CHEAP Investor and The Konlin Letter.
On the verge of breaking out to its 1st objective up to the $5-$6 area, which will bring
a
Nasdaq National Market Listing to Fonar.
As a result of its new products OPEN FIELD MRI & the OR-360 and ongoing
research and development. FONR has positioned itself to dramatically increase sales
and improve its competitive position in the market place. FONR is truly the leading
pioneer in MRI technology. FONR also has recently purchased a total of 32 Physician
Practice Management Centers, the first of which resulted in the showing of a Profit in
it's
first Quarter. FONR Stands on the threshold of dramatic global growth.
Konlin Letter has a "Buy Recommendation" for an ultimate target up to the $9 to $10
area."
Fonar has an upcoming lawsuit against Toshiba for infringing on 4 of Fonar's MRI
patents, was recently SETTLED with Toshiba paying Fonar an UNDISCLOSED amount of money. Two of these patent infringements were the very same two in which General
Electric paid Fonar the $128.7 Million in July 1997.
It is only logical that Fonar would win these two of the 4. The remaining 2 were for
OPEN FIELD MRI. Also these patent suits against Toshiba were for "WILLFUL
INFRINGEMENT" which carries much greater damages and is very likely WHY Toshiba decided to Settle. Fonar now has a foot in the door to
turn the OPEN FIELD MRI world
upside down. All the LARGE companies will likely scramble to make some kind of
arrangement with Fonar.
It appears that The Street has over-looked Fonar's accomplishments & potential,
some
of which are.
(1) Current stock price is very near a 3 year low, with Fonar in MUCH, MUCH
better
shape than 3 years ago.
(2) No long term debt.
(3) $80 MILLION in CASH after lawyer fees just from GE alone. Royalties being paid by several previous settlements.
(4) NEW TECHNOLOGY which includes the 0R-360, which was introduced at the Largest Radiologist Show in the World in Dec. 1997.
(5) New patent infringement lawsuits filed against 3 more companies.
(6) Just recently closed a deal with a Financial PR Firm.
(7) Institutional firms accumulating stock.
(8) Talks began July 27, 98 with several Small Cap Stock Funds
CHEAP Investor made this statement in the August
issue about Fonar Corp. (FONR)This issue just came out, and I
think this could have a HUGE impact....
"Fonar is gearing up to manufacture a lot of Quad scanners and OR-360's. The
company thinks the market for the new surgical technology is huge and Fonar could be
a major player in this emerging field. We've learned that some of the recent patent
infringement agreements between Fonar and the companies it sued (i.e. Toshiba, etc.)
restrain them from competing in this new marketplace. That's a creative tactic to
reduce
competition."
As I read that , logically one must assume that to mean it is quite possible that the 3
other companies may
have SETTLED already. PLUS that kind of agreement has to be HUGE, not to
mention
the CASH..
These statements are believed to be accurate and may be forward looking, which may
or may not occur. This is not a suggestion to buy or sell stock. I am an investor and a
stock holder and nothing else. I am not a financial advisor and thus take no
responsibility
for profit or loss in this or any other stock which I may post information on from time
to
time.
This information is provided solely for the purpose of your own due diligence and
research purpose.
My intent is to make you aware of a company which in my personal opinion, is way
undervalued, with GREAT GROWTH and PROFIT POTENTIAL.........Use of this
information to buy, sell or otherwise is a decision you must make on your own, May it
be a profitable one.
Regards,
Malcolm Lindsey |
